Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > The effects of trazodone on human cognition: a systematic review
Publication

Publications

The effects of trazodone on human cognition: a systematic review

Title
The effects of trazodone on human cognition: a systematic review
Type
Article in International Scientific Journal
Year
2021
Authors
Gonçalo, AMG
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
vieira-coelho, ma
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
ISSN: 0031-6970
Publisher: Springer Nature
Indexing
Other information
Authenticus ID: P-00V-1AC
Abstract (EN): Trazodone is a widely used antidepressant that is also useful in the control of agitation and insomnia in Alzheimer's disease. This drug is now recognized as having a new mechanism of action, an effect on the unfolded protein response (UPR) pathway, restoring protein translation and slowing neurodegenerative progression in mice. This mechanism may have a role in dementia-modifying treatment. To explore the effects of trazodone on human cognition and to search for clinical evidence of its putative benefits in human neurodegenerative diseases, a systematic review was conducted for studies that evaluated the effect of a minimum dose of 25 mg of trazodone daily, for at least 1 week, on cognition in adult humans. The search was run in MEDLINE, Web of Science, and CENTRAL from the Cochrane databases, yielding a total of 16 studies after selection. Overall, seven studies showed no effect of trazodone on cognition, five showed a beneficial effect by improving or reducing cognitive decline, and four evidenced impaired cognitive function. Our analysis highlights the possibility of a dose-independent dual effect of trazodone on human cognition, with acute utilization associated with impaired cognitive function and long-term use with preventing cognitive deterioration. There was no clinical evidence that trazodone could be used as a specific treatment of neurodegenerative diseases. Future studies should explore the role of trazodone in the UPR pathway and the implications in neurodegenerative diseases in humans. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM) (2011)
Another Publication in an International Scientific Journal
Souto, SB; Souto, EB; Braga, DC; Medina, JL
Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24 (2017)
Another Publication in an International Scientific Journal
Borba, HH; Wiens, A; Steimbach, LM; Perlin, CM; Tonin, FS; Pedroso, MLA; Fernandez Llimos, F; Pontarolo, R
Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis (2018)
Another Publication in an International Scientific Journal
Tonin, FS; Steimbach, LM; Leonart, LP; Ferreira, VL; Borba, HH; Piazza, T; Araujo, AG; Fernandez Llimos, F; Pontarolo, R; Wiens, A
Why healthy subjects volunteer for phase I studies and how they perceive their participation? (2007)
Article in International Scientific Journal
Almeida, L; Azevedo, B; Nunes, T; Vaz Da Silva, M; soares-da-silva, p
Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events (2008)
Article in International Scientific Journal
Almeida, L; Kashdan, TB; Nunes, T; Coelho, R; Albino Teixeira, A; soares-da-silva, p

See all (17)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-16 at 04:45:45 | Privacy Policy | Personal Data Protection Policy | Whistleblowing